Ribavirin and lethal mutagenesis of poliovirus: molecular mechanisms, resistance and biological implications.
暂无分享,去创建一个
[1] D. Smee,et al. Selective inhibition of arthropod-borne and arenaviruses in vitro by 3'-fluoro-3'-deoxyadenosine. , 1992, Antiviral research.
[2] M. Bouloy,et al. Quantitative Real-Time PCR Detection of Rift Valley Fever Virus and Its Application to Evaluation of Antiviral Compounds , 2001, Journal of Clinical Microbiology.
[3] P. McNamara,et al. Pharmacokinetics and Absolute Bioavailability of Ribavirin in Healthy Volunteers as Determined by Stable-Isotope Methodology , 1999, Antimicrobial Agents and Chemotherapy.
[4] E. Domingo,et al. Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV). , 2003, Virology.
[5] R. Garofalo,et al. Ribavirin Treatment Up-Regulates Antiviral Gene Expression via the Interferon-Stimulated Response Element in Respiratory Syncytial Virus-Infected Epithelial Cells , 2003, Journal of Virology.
[6] F. V. van Tiel,et al. Inhibition of Semliki Forest virus multiplication by ribavirin: a potential method for the monitoring of antiviral agents in serum. , 1986, Journal of virological methods.
[7] V. Racaniello. Picornaviridae : the viruses and their replication , 2001 .
[8] J. Patterson,et al. Molecular mechanisms of action of ribavirin. , 1990, Reviews of infectious diseases.
[9] Freer Cb. Care of the elderly. Old myths. , 1985 .
[10] A. Jouan,et al. Inhibition of sandfly fever Sicilian virus (Phlebovirus) replication in vitro by antiviral compounds. , 1997, Research in virology.
[11] E. Domingo,et al. Origin and Evolution of Viruses , 2010, Virus Genes.
[12] Identification of a Ribavirin‐resistant NS5B mutation of hepatitis C virus during ribavirin monotherapy , 2003, Hepatology.
[13] V. Knight,et al. Effects of selenazofurin and ribavirin and their 5'-triphosphates on replicative functions of influenza A and B viruses , 1986, Antimicrobial Agents and Chemotherapy.
[14] J. Patterson,et al. Ribavirin is an inhibitor of human immunodeficiency virus reverse transcriptase. , 1990, Molecular pharmacology.
[15] M. Eigen. On the nature of virus quasispecies. , 1996, Trends in microbiology.
[16] L. M. Mansky,et al. Retrovirus mutation rates and their role in genetic variation. , 1998, The Journal of general virology.
[17] J. Bard,et al. Contact hypersensitivity responses following ribavirin treatment in vivo are influenced by type 1 cytokine polarization, regulation of IL-10 expression, and costimulatory signaling. , 1999, Journal of immunology.
[18] J. Drake. A constant rate of spontaneous mutation in DNA-based microbes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[19] V. Knight,et al. Effect of ribavirin triphosphate on primer generation and elongation during influenza virus transcription in vitro. , 1985, Antiviral research.
[20] D. Smee,et al. Visna virus as an in vitro model for human immunodeficiency virus and inhibition by ribavirin, phosphonoformate, and 2',3'-dideoxynucleosides , 1987, Antimicrobial Agents and Chemotherapy.
[21] E. Domingo,et al. Pol gene quasispecies of human immunodeficiency virus: mutations associated with drug resistance in virus from patients undergoing no drug therapy , 1995, Journal of virology.
[22] E. Domingo,et al. Rapid evolution of viral RNA genomes. , 1997, The Journal of nutrition.
[23] P. Wyde. Respiratory syncytial virus (RSV) disease and prospects for its control. , 1998, Antiviral research.
[24] M. Hosoya,et al. The cooperative effect of interferon-alpha and ribavirin on subacute sclerosing panencephalitis (SSPE) virus infections, in vitro and in vivo. , 1998, Antiviral research.
[25] Rong Liu,et al. The effect of ribavirin and IMPDH inhibitors on hepatitis C virus subgenomic replicon RNA. , 2003, Virology.
[26] J. McCormick,et al. Antiviral effect of ribavirin on Junin virus replication in vitro. , 1986, Revista Argentina de microbiologia.
[27] M. von Wagner,et al. Effect of ribavirin on virus load and quasispecies distribution in patients infected with hepatitis C virus. , 1998, Journal of hepatology.
[28] C. Cameron,et al. Pleiotropic mechanisms of ribavirin antiviral activities. , 2002, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.
[29] David A. Steinhauer,et al. Mutation Frequencies at Defined Single Codon Sites in Vesicular Stomatitis Virus and Poliovirus Can Be Increased Only Slightly by Chemical Mutagenesis , 1990, Journal of virology.
[30] B. Chiang,et al. Ribavirin enhancement of hepatitis C virus core antigen-specific type 1 T helper cell response correlates with the increased IL-12 level. , 2000, Journal of hepatology.
[31] William E. Severson,et al. Ribavirin Causes Error Catastrophe during Hantaan Virus Replication , 2003, Journal of Virology.
[32] M. Eigen. Selforganization of matter and the evolution of biological macromolecules , 1971, Naturwissenschaften.
[33] S. Elena,et al. Basic concepts in RNA virus evolution , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[34] T. Briese,et al. Inhibition of Borna Disease Virus Replication by Ribavirin , 1999, Journal of Virology.
[35] V. Knight,et al. Mode of action of ribavirin: effect of nucleotide pool alterations on influenza virus ribonucleoprotein synthesis. , 1985, Antiviral research.
[36] G. Davis,et al. Modulation of hepatitis C virus quasispecies heterogeneity by interferon‐α and ribavirin therapy , 1997 .
[37] E. Domingo,et al. RNA virus mutations and fitness for survival. , 1997, Annual review of microbiology.
[38] J. Drake. Rates of spontaneous mutation among RNA viruses. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[39] O. Weiland,et al. The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses. , 1998, The Journal of general virology.
[40] C. Cameron,et al. Hepatitis C Virus RNA-dependent RNA Polymerase (NS5B) as a Mediator of the Antiviral Activity of Ribavirin* , 2001, The Journal of Biological Chemistry.
[41] M. Eigen,et al. Statistical geometry in sequence space: a method of quantitative comparative sequence analysis. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[42] E. De Clercq,et al. Use of Cotton Rats to Evaluate the Efficacy of Antivirals in Treatment of Measles Virus Infections , 2000, Antimicrobial Agents and Chemotherapy.
[43] Julie K. Pfeiffer,et al. A single mutation in poliovirus RNA-dependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[44] E. Domingo,et al. Viral quasispecies and the problem of vaccine-escape and drug-resistant mutants. , 1997, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.
[45] D. Smee,et al. Antiviral Activity and Mode of Action Studies of Ribavirin and Mycophenolic Acid against Orthopoxviruses in Vitro , 2001, Antiviral chemistry & chemotherapy.
[46] Gideon Koren,et al. Ribavirin in the treatment of SARS: A new trick for an old drug? , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[47] J. Mullins,et al. Lethal mutagenesis of HIV with mutagenic nucleoside analogs. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[48] H. Temin,et al. Retrovirus variation and reverse transcription: abnormal strand transfers result in retrovirus genetic variation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[49] F. Sobrino,et al. Cuasiespecies y evolución molecular de virus , 2000 .
[50] Pedro R. Lowenstein,et al. Response of Foot-and-Mouth Disease Virus to Increased Mutagenesis: Influence of Viral Load and Fitness in Loss of Infectivity , 2000, Journal of Virology.
[51] T. Mizutani,et al. Characterization of in vitro and in vivo antiviral activity of lactoferrin and ribavirin upon hantavirus. , 2001, The Journal of veterinary medical science.
[52] E. Domingo,et al. Lack of evidence for proofreading mechanisms associated with an RNA virus polymerase. , 1992, Gene.
[53] C. Cameron,et al. RNA virus error catastrophe: Direct molecular test by using ribavirin , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[54] T. Yamase,et al. Synergistic anti-influenza virus A (H1N1) activities of PM-523 (polyoxometalate) and ribavirin in vitro and in vivo , 1997, Antimicrobial agents and chemotherapy.
[55] Stephen S. Morse,et al. The Evolutionary biology of viruses , 1994 .
[56] G. Boivin,et al. Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro. , 2003, Antiviral research.
[57] E. Schmidt,et al. Viral RNA Mutations Are Region Specific and Increased by Ribavirin in a Full-Length Hepatitis C Virus Replication System , 2002, Journal of Virology.
[58] D. Nash,et al. Inhibition of Crimean-Congo hemorrhagic fever viral infectivity yields in vitro by ribavirin. , 1989, The American journal of tropical medicine and hygiene.
[59] E. Domingo,et al. RNA virus fitness , 1997, Reviews in medical virology.
[60] Isabelle Bougie,et al. The Broad Spectrum Antiviral Nucleoside Ribavirin as a Substrate for a Viral RNA Capping Enzyme* , 2004, Journal of Biological Chemistry.
[61] J. Holland,et al. RNA virus populations as quasispecies. , 1992, Current topics in microbiology and immunology.
[62] J. Drake,et al. The Distribution of Rates of Spontaneous Mutation over Viruses, Prokaryotes, and Eukaryotes , 1999, Annals of the New York Academy of Sciences.
[63] J. Huggins. Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug. , 1989, Reviews of infectious diseases.
[64] J. Arnold,et al. The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen , 2000, Nature Network Boston.
[65] E. Domingo,et al. Viruses at the edge of adaptation. , 2000, Virology.
[66] J. McCormick,et al. RIBAVIRIN SUPPRESSES REPLICATION OF LYMPHADENOPATHY-ASSOCIATED VIRUS IN CULTURES OF HUMAN ADULT T LYMPHOCYTES , 1984, The Lancet.
[67] J. Hansen,et al. Structure of the RNA-dependent RNA polymerase of poliovirus. , 1997, Structure.
[68] A. Meyerhans,et al. The Fidelity of Cellular and Viral polymerases and its manipulation for Hypermutagenesis , 1999 .
[69] T. Briese,et al. Ribavirin inhibits West Nile virus replication and cytopathic effect in neural cells. , 2000, The Journal of infectious diseases.
[70] Z. Hong,et al. Mechanisms of Action of Ribavirin in Antiviral Therapies , 2001, Antiviral chemistry & chemotherapy.
[71] J. Holland,et al. Extreme heterogeneity in populations of vesicular stomatitis virus , 1989, Journal of virology.
[72] J. McCormick,et al. Lassa fever. Effective therapy with ribavirin. , 1986, The New England journal of medicine.
[73] E. Domingo,et al. Quasispecies structure and persistence of RNA viruses. , 1998, Emerging infectious diseases.
[74] E. De Clercq,et al. Molecular approaches for the treatment of hemorrhagic fever virus infections. , 1993, Antiviral research.
[75] J. Arnold,et al. Poliovirus RNA-dependent RNA polymerase (3D(pol)). Assembly of stable, elongation-competent complexes by using a symmetrical primer-template substrate (sym/sub). , 2000, The Journal of biological chemistry.
[76] E. Domingo,et al. Curing of foot-and-mouth disease virus from persistently infected cells by ribavirin involves enhanced mutagenesis. , 2003, Virology.
[77] M. Eigen. Viral quasi species. , 1993 .
[78] J. Arnold,et al. Poliovirus RNA-dependent RNA Polymerase (3Dpol) , 2000, The Journal of Biological Chemistry.
[79] U. Phan,et al. Ribavirin polarizes human T cell responses towards a Type 1 cytokine profile. , 1999, Journal of hepatology.
[80] R. Lanford,et al. Ribavirin Induces Error-Prone Replication of GB Virus B in Primary Tamarin Hepatocytes , 2001, Journal of Virology.
[81] M. Lai,et al. Mutagenic and inhibitory effects of ribavirin on hepatitis C virus RNA polymerase. , 2003, Biochemistry.
[82] Manfred Eigen,et al. Error catastrophe and antiviral strategy , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[83] C. Cameron,et al. The mechanism of action of ribavirin: lethal mutagenesis of RNA virus genomes mediated by the viral RNA-dependent RNA polymerase , 2001, Current opinion in infectious diseases.
[84] Z. Hong,et al. Mechanism of action of ribavirin in the combination treatment of chronic HCV infection , 2002, Hepatology.
[85] Ming Liu,et al. Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response. , 1998, Journal of immunology.
[86] M. Roggendorf,et al. Inhibition of hepatitis delta virus RNA replication in primary woodchuck hepatocytes. , 1989, Antiviral research.
[87] P. Jahrling,et al. EXPERIMENTAL LASSA FEVER VIRUS INFECTION SUCCESSFULLY TREATED WITH RIBAVIRIN , 1979, The Lancet.
[88] Katherine Spindler,et al. Rapid evolution of RNA genomes. , 1982, Science.
[89] Natale Scaramozzino,et al. Interferon, ribavirin, 6-azauridine and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses. , 2003, Antiviral research.
[90] B. K. Murray,et al. The importance of IMP dehydrogenase inhibition in the broad spectrum antiviral activity of ribavirin and selenazofurin. , 1985, Advances in enzyme regulation.